Scientific publications

Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer
Virginie Pichard, Mickaël Guilbaud, Marie Devaux, Nicolas Jaulin, Malo Journou, Magalie Cospolite, Alexandra Garcia, Nicolas Ferry, Sophie Michalak-Provost, Gwladys Gernoux, Oumeya Adjali
Gene Ther. 2025 Jan 21. doi: 10.1038/s41434-025-00514-z.

The ambition for a one-and-done vision-saving AAV vector
Therese Cronin
Mol Ther Methods Clin Dev. 2025 Feb 3;33(1):101414. doi: 10.1016/j.omtm.2025.101414. eCollection 2025 Mar 13.

Generation of a compound heterozygous ABCA4 rat model with pathological features of STGD1.
Morival C, Croyal M, Remy S, Mortier E, Libeau L, Veziers J, Provost N, Demilly J, Mendes-Madeira A, Isiegas C, Tesson L, Anegon I, Adjali O, Cronin T.
Hum Mol Genet. 2025 Apr 24:ddaf057. doi: 10.1093/hmg/ddaf057. Online ahead of print.

AAV-mediated inner ear gene delivery triggers mild host immune responses in the mammalian inner ear.
Ishibashi Y, Zhu J, Gernoux G, Yu Y, Suh MJ, Isgrig K, Grati M, Olszewski R, Hoa M, Liang C, Friedman TB, Adjali O, Chien WW.
Mol Ther Methods Clin Dev. 2025 Mar 21;33(2):101456. doi: 10.1016/j.omtm.2025.101456. eCollection 2025 Jun 12.

Ligand-modified rAAV6 vectors with nanoblades allow high-level gene knockin in HSPCs without compromising cell survival.
Gutierrez-Guerrero A, Périan S, Leray A, Martinello C, Abrey Recalde MJ, Costa C, Herrero CI, Bouzelha M, Alvarez-Dorta D, Gouin SG, Ayuso E, Adjali O, Büning H, Deniaud D, Mével M, Verhoeyen E.
Mol Ther Nucleic Acids. 2025 Feb 22;36(2):102495. doi: 10.1016/j.omtn.2025.102495. eCollection 2025 Jun 10.

Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient.
Journou M, Devaux M, Jaulin N, Pichard V, Segovia M, Moreau A, Le Duff J, Cuturi MC, Guilbaud M, Adjali O.
Mol Ther Methods Clin Dev. 2025 Jan 19;33(1):101409. doi: 10.1016/j.omtm.2025.101409. eCollection 2025 Mar 13.

Bioorthogonal Chemical Engineering of rAAV Capsid: Advancing Gene Therapy Targeting Using Proteins.
Marchand M, Depienne S, Bouzelha M, Pavageau K, Peumery R, Loquet D, Alvarez-Dorta D, Guilbaud M, Croyal M, Dupont A, Adjali O, Gouin SG, Deniaud D, Mével M.
Bioconjug Chem. 2025 Mar 19;36(3):521-530. doi: 10.1021/acs.bioconjchem.4c00580. Epub 2025 Feb 24.

One-year risk of multiple sclerosis after a first episode of optic neuritis according to modern diagnosis criteria.
Lebranchu P, Mazhar D, Wiertlewski S, Le Meur G, Couturier J, Ducloyer JB.
Mult Scler Relat Disord. 2025 Jan;93:106213. doi: 10.1016/j.msard.2024.106213. Epub 2024 Dec 9.

Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency.
Mével M, Pichard V, Bouzelha M, Alvarez-Dorta D, Lalys PA, Provost N, Allais M, Mendes A, Landagaray E, Ducloyer JB, Toublanc E, Galy A, Brument N, Lefevre GM, Gouin SG, Isiegas C, Le Meur G, Cronin T, Le Guiner C, Weber M, Moullier P, Ayuso E, Deniaud D, Adjali O.
Mol Ther Methods Clin Dev. 2024 Jan 17;32(1):101187. doi: 10.1016/j.omtm.2024.101187. eCollection 2024 Mar 14.

Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina.
Leray A, Lalys PA, Varin J, Bouzelha M, Bourdon A, Alvarez-Dorta D, Pavageau K, Depienne S, Marchand M, Mellet A, Demilly J, Ducloyer JB, Girard T, Fraysse B, Ledevin M, Guilbaud M, Gouin SG, Ayuso E, Adjali O, Larcher T, Cronin T, Le Guiner C, Deniaud D, Mével M.
Biomed Pharmacother. 2024 Feb;171:116148. doi: 10.1016/j.biopha.2024.116148. Epub 2024 Jan 16.

Prevalence Study of Cellular Capsid-Specific Immune Responses to AAV2, 4, 5, 8, 9, and rh10 in Healthy Donors.
Xicluna R, Avenel A, Vandamme C, Devaux M, Jaulin N, Couzinié C, Le Duff J, Charrier A, Guilbaud M, Adjali O, Gernoux G. Hum Gene Ther. 2024 May;35(9-10):355-364. doi: 10.1089/hum.2023.225. Epub 2024 Apr 19. PMID: 38581431

Dystrophin deficiency impairs cell junction formation during embryonic myogenesis.
Mozin E, Massouridès E, Mournetas V, Lièvre C, Bourdon A, Jackson DL, Packer JS, Seong J, Trapnell C, Le Guiner C, Adjali O, Pinset C, Mack DL, Dupont JB. bioRxiv [Preprint]. 2024 Apr 8:2023.12.05.569919. doi: 10.1101/2023.12.05.569919. PMID: 38106055

Characterization of residual microRNAs in AAV vector batches produced in HEK293 mammalian cells and Sf9 insect cells.
Penaud-Budloo M, Lecomte E, Lecomte Q, Pacouret S, Broucque F, Guy-Duché A, Dupont JB, Jeanson-Leh L, Robin C, Blouin V, Ayuso E, Adjali O. Mol Ther Methods Clin Dev. 2024 Jul 25;32(3):101305. doi: 10.1016/j.omtm.2024.101305. eCollection 2024 Sep 12. PMID: 39220637 Free PMC article.

Dystrophin deficiency impairs cell junction formation during embryonic myogenesis.
Mozin E, Massouridès E, Mournetas V, Lièvre C, Bourdon A, Jackson DL, Packer JS, Trapnell C, Guiner CL, Adjali O, Pinset C, Mack DL, Dupont JB.
bioRxiv [Preprint]. 2023 Dec 7:2023.12.05.569919. doi: 10.1101/2023.12.05.569919.

Management of safety issues arising following AAV gene therapy.
261st ENMC International Workshop 17th-19th June 2022, Hoofddorp, The Netherlands.
Servais L, Horton R, Saade D, Bonnemann C, Muntoni F; 261st ENMC workshop study group.
Neuromuscul Disord. 2023 Nov;33(11):884-896. doi: 10.1016/j.nmd.2023.09.008. Epub 2023 Oct 1.

Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy.
Le Guiner C, Xiao X, Larcher T, Lafoux A, Huchet C, Toumaniantz G, Adjali O, Anegon I, Remy S, Grieger J, Li J, Farrokhi V, Neubert H, Owens J, McIntyre M, Moullier P, Samulski RJ.
Mol Ther Methods Clin Dev. 2023 May 18;30:30-47. doi: 10.1016/j.omtm.2023.05.017. eCollection 2023 Sep 14.

Transcriptomic Analysis Reveals the Inability of Recombinant AAV8 to Activate Human Monocyte-Derived Dendritic Cells.
Masri S, Carré L, Jaulin N, Vandamme C, Couzinié C, Guy-Duché A, Dupont JB, Pereira A, Charpentier E, David L, Gernoux G, Guilbaud M, Adjali O.
Int J Mol Sci. 2023 Jun 21;24(13):10447. doi: 10.3390/ijms241310447.

Analytical ultracentrifugation sedimentation velocity for the characterization of recombinant adeno-associated virus vectors sub-populations.
Saleun S, Mas C, Le Roy A, Penaud-Budloo M, Adjali O, Blouin V, Ebel C.
Eur Biophys J. 2023 Jul;52(4-5):367-377. doi: 10.1007/s00249-023-01650-3. Epub 2023 Apr 28.

Click-electrochemistry for the rapid labeling of virus, bacteria and cell surfaces.
Depienne S, Bouzelha M, Courtois E, Pavageau K, Lalys PA, Marchand M, Alvarez-Dorta D, Nedellec S, Marín-Fernández L, Grandjean C, Boujtita M, Deniaud D, Mével M, Gouin SG.
Nat Commun. 2023 Aug 23;14(1):5122. doi: 10.1038/s41467-023-40534-0.

Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMD rat model
Bourdon A., François V., Zhang L., Lafoux A., Fraysse B., Toumaniantz G., Larcher T., Girard T., Ledevin M., Lebreton C., Hivonnair A., Creismeas A., Allais M., Marie B., Guguin J., Blouin V., Rémy S., Anegon I., Huchet C., Malerba A., Kao B., Le Héron A., Moullier P., Dickson G., Popplewell L., Adjali O., Montanaro F. and Le Guiner C.
Gene Ther (2022). https://doi.org/10.1038/s41434-022-00317-6
 

The Diversity of Parvovirus Telomeres
Marianne Laugel, Emilie Lecomte, Eduard Ayuso, Oumeya Adjali, Mathieu Mével and Magalie Penaud-BudlooBlouin
Recent Advances in Canine Medicine - DOI: 10.5772/intechopen.102684 - April 27th, 2022

Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity
Tran NT, Lecomte E, Saleun S, Namkung S, Robin C, Weber K, Devine E, Blouin V, Adjali O, Ayuso E, Gao G, Penaud-Budloo M, Tai PWL.
Hum Gene Ther. 2022 Apr;33(7-8):371-388. doi: 10.1089/hum.2022.050

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
Ferrari S, Jacob A, Cesana D, Laugel M, Beretta S, Varesi A, Unali G, Conti A, Canarutto D, Albano L, Calabria A, Vavassori V, Cipriani C, Castiello MC, Esposito S, Brombin C, Cugnata F, Adjali O, Ayuso E, Merelli I, Villa A, Di Micco R, Kajaste-Rudnitski A, Montini E, Penaud-Budloo M, Naldini L.
Cell Stem Cell. 2022 Oct 6;29(10):1428-1444.e9. doi: 10.1016/j.stem.2022.09.001.

Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distribution.
Ducloyer JB, Pichard V, Mevel M, Galy A, Lefevre GM, Brument N, Alvarez-Dorta D, Deniaud D, Mendes-Madeira A, Libeau L, Le Guiner C, Cronin T, Adjali O, Weber M, Le Meur G.
Mol Ther Methods Clin Dev. 2023 Feb 15;28:387-393. doi: 10.1016/j.omtm.2023.02.006. eCollection 2023 Mar 9.

Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice.
Calabria A, Cipriani C, Spinozzi G, Rudilosso L, Esposito S, Benedicenti F, Albertini A, Pouzolles M, Luoni M, Giannelli S, Broccoli V, Guilbaud M, Adjali O, Taylor N, Zimmermann VS, Montini E, Cesana D.
Blood. 2023 May 11;141(19):2316-2329. doi: 10.1182/blood.2022017378.

AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation
Gwladys Gernoux , Mickaël Guilbaud , Marie Devaux , Malo Journou , Virginie Pichard , Nicolas Jaulin , Adrien Léger , Johanne Le Duff , Jack-Yves Deschamps , Caroline Le Guiner , Philippe Moullier , Yan Cherel , Oumeya Adjali
Mol Ther Methods Clin Dev. 2021 Feb 6;20:660-674. doi: 10.1016/j.omtm.2021.02.003. eCollection 2021 Mar 12.

Homologous Recombination Offers Advantages over Transposition-Based Systems to Generate Recombinant Baculovirus for Adeno-Associated Viral Vector Production
Jacob A, Brun L, Jiménez Gil P, Ménard L, Bouzelha M, Broucque F, Roblin A, Vandenberghe LH, Adjali O, Robin C, François A, Blouin V, Penaud-Budloo M, Ayuso E.
Biotechnol J. 2021 Jan;16(1):e2000014. doi: 10.1002/biot.202000014. Epub 2020 Nov 16.PMID: 33067902

The SSV-Seq 2.0 PCR-Free Method Improves the Sequencing of Adeno-Associated Viral Vector Genomes Containing GC-Rich Regions and Homopolymers
Lecomte E, Saleun S, Bolteau M, Guy-Duché A, Adjali O, Blouin V, Penaud-Budloo M, Ayuso E.
Biotechnol J. 2021 Jan;16(1):e2000016. doi: 10.1002/biot.202000016. Epub 2020 Nov 8.PMID: 33064875

Genetic diseases in the omics era
Jean-Baptiste Dupont,
Mol Ther. 2021 Aug 4;29(8):2389-2390. doi: 10.1016/j.ymthe.2021.07.007. Epub 2021 Jul 23

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD
Anna Creisméas, Claire Gazaille, Audrey Bourdon, Marc-Antoine Lallemand, Virginie François, Marine Allais, Mireille Ledevin, Thibaut Larcher, Gilles Toumaniantz, Aude Lafoux, Corinne Huchet, Ignacio Anegon, Oumeya Adjali, Caroline Le Guiner, Bodvaël Fraysse
J Transl Med. 2021 Dec 20;19(1):519. doi: 10.1186/s12967-021-03191-9.

Luminol anchors improve the electrochemical-tyrosine-click labelling of proteins.
Depienne S, Alvarez-Dorta D, Croyal M, Temgoua RCT, Charlier C, Deniaud D, Mével M, Boujtita M, Gouin SG.
Chem Sci. 2021 Nov 10;12(46):15374-15381. doi: 10.1039/d1sc04809k. eCollection 2021 Dec 1.

Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8 + T Cells in Human Donors Allows the Detection of a T EMRA Subpopulation.
Vandamme C, Xicluna R, Hesnard L, Devaux M, Jaulin N, Guilbaud M, Le Duff J, Couzinié C, Moullier P, Saulquin X, Adjali O.
Front. Immunol., 21 January 2020. doi: 10.3389/fimmu.2019.03110

Tyrosine Conjugation Methods for Protein Labelling
Dimitri Alvarez Dorta, David Deniaud, Mathieu Mével, Sébastien G Gouin
Chemistry. 2020 Jun 15. doi: 10.1002/chem.202001992. Online ahead of print.

Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
Karim Bey, Johan Deniaud, Laurence Dubreil, Béatrice Joussemet, Joseph Cristini, Carine Ciron, Juliette Hordeaux, Morwenn Le Boulc’h, Kevin Marche, Maud Maquigneau, Michaël Guilbaud, Rosalie Moreau, Thibaut Larcher, Jack-Yves Deschamps, Marion Fusellier, Véronique Blouin, Caroline Sevin, Nathalie Cartier, Oumeya Adjali, Patrick Aubourg, Philippe Moullier, and Marie-Anne Colle
Mol Ther Methods Clin Dev. 2020 Apr 11;17:771-784. doi: 10.1016/j.omtm.2020.04.001. eCollection 2020 Jun 12.

Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model.
Caudal D, François V, Lafoux A , Ledevin M,  Anegon I,  Le Guiner C , Larcher T, Huchet C.
PLoS One 2020 Mar 11;15(3):e0230083. doi : 10.1371/journal.pone.0230083

The Contractile Phenotype of Skeletal Muscle in TRPV1 Knockout Mice is Gender-Specific and Exercise-Dependent.
Lafoux A, Lotteau S, Huchet C, Ducreux S.
Life (Basel). 2020 Oct 6;10(10):E233. doi: 10.3390/life10100233.

2019

Single-Stranded DNA Virus Sequencing (SSV-Seq) for Characterization of Residual DNA and AAV Vector Genomes.
Lecomte E, Leger A, Penaud-Budloo M, Ayuso E.
Methods Mol Biol. 2019;1950:85-106. doi: 10.1007/978-1-4939-9139-6_5.

5 years of successful inducible transgene expression following locoregional AAV delivery in nonhuman primates with no detectable immunity.
Guilbaud M, Devaux M, Couzinié C, Le Duff J, Toromanoff A, Vandamme C, Jaulin N, Gernoux G, Larcher T, Moullier P1, Le Guiner C, Adjali O
Hum Gene Ther. 2019 Feb 27. doi: 10.1089/hum.2018.234.

Stability of the adeno-associated virus 8 reference standard material.
Penaud-Budloo M, Broucque F, Harrouet K, Bouzelha M, Saleun S, Douthe S, D'Costa S, Ogram S, Adjali O, Blouin V, Lock M, Snyder RO, Ayuso E.
Gene Ther. Mar 29. doi: 10.1038/s41434-019-0072-9. 2019

Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of Adeno-Associated Virus Serotypes.
Rieser R, Penaud-Budloo M, Bouzelha M, Rossi A, Menzen T, Biel M, Büning H, Ayuso E, Winter G, Michalakis S.
J Pharm Sci. 2019 Oct 19. doi:10.1016/j.xphs.2019.10.031.

Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells.
Pouzolles M, Machado A*, Guilbaud M*, Irla M, Gailhac S, Barennes P, Cesana D, Calabria A, Benedicenti F, Serge A, Raman I, Li QZ, Montini E, Klatzmann D, Adjali O, Taylor N and Zimmermann VS
The journal of allergy and Clinical immunology, 2019 Sep 9. pii: S0091-6749(19)31171-6. doi: 10.1016/j.jaci.2019.08.029.

Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries.
Schmit PF, Pacouret S, Zinn E, Telford E, Nicolaou F, Broucque F, Andres-Mateos E, Xiao R, Penaud-Budloo M, Bouzelha M, Jaulin N, Adjali O, Ayuso E, Vandenberghe LH
Mol Ther Methods Clin Dev. 2019 Nov 26;17:107-121. doi : 10.1016/j.omtm.2019.11.014. eCollection 2020 Jun 12.

Chemical modification of adeno-associated virus capsid to improve gene delivery
Mével M, Bouzelha M, Leray A, Pacouret S, Guilbaud M, Penaud-Budloo M, Alvarez-Dorta D, Dubreuil L, Gouin SG, Combal JP, Hommel M, Gonzalez-Aseguinolaza G, Blouin V, Moullier P, Adjali A, Deniaud D, Ayuso E.
Chemical Science, 9 December 2019, doi : 10.1039/C9SC04189C

O-GlcNAc stimulation: A new metabolic approach to treat spetic shock.
Ferron M, Cadiet J, Persello A, Prat V, Denis M, Erraud A, Aillerie V, Mével M, Bogot E, Chatham JC, Gauthier C, Rozec B, Lauzier B.
Nature scientific report, 10 December 2019, doi : 10.1038/s41598-019-55381-7

Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment.
Ouisse LH, Remy S, Lafoux A, Larcher T, Tesson L, Chenouard V, Guillonneau C, Brusselle L, Vimond N, Rouger K, Péréon Y, Chenouard A, Gras-Le Guen C, Braudeau C, Josien R, Huchet C, Anegon I.
Front Immunol. 2019 Sep 9;10:2131. doi: 10.3389/fimmu.2019.02131. eCollection 2019

2018

RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect.
Domenger C, Allais M, François V, Léger A, Lecomte E, Montus M, Servais L, Voit T, Moullier P, Audic Y, Le Guiner C.
Mol Ther Nucleic Acids. 2018 Mar 2;10:277-291. doi: 10.1016/j.omtn.2017.12.008. Epub 2017 Dec 21.

Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.
Le Meur G, Lebranchu P, Billaud F, Adjali O, Schmitt S, Bézieau S, Péréon Y, Valabregue R, Ivan C, Darmon C, Moullier P, Rolling F, Weber M.
Mol Ther. 2018 Jan 3;26(1):256-268. doi: 10.1016/j.ymthe.2017.09.014. Epub 2017 Sep 19.

Pharmacology of recombinant adeno-associated virus production.
Penaud-Budloo M, François A, Clément N, Ayuso E.
Molecular Therapy: Methods & Clinical Development (2018), doi: 10.1016/j.omtm.2018.01.002.

Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits.
Lorant J, Larcher T, Jaulin N, Hedan B, Lardenois A, Leroux I, Dubreil L, Ledevin M, Goubin H, Moullec S, JY, Thorin C, André C, Adjali O, Rouger K
Cell Transplantation, First Published June 5, 2018, doi : 10.1177/0963689718776306

The Assembly-Activating Protein Promotes Stability and Interactions between AAV’s Viral Proteins to Nucleate Capsid Assembly.
Anna Maurer, Simon Pacouret, Ana Karla Cepeda Diaz, Jessica Blake, Eva Andres-Mateos, Luk Vandenberghe
Cell Reports , Elsevier Inc, 23 (6), pp.1817 - 1830, doi : 10.1016/j.celrep.2018.04.026

Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls.
François A, Bouzelha M, Lecomte E, Broucque F, Penaud-Budloo M, Adjali O, Moullier P, Blouin V, Ayuso E.
Mol Ther Methods Clin Dev. 2018 Jul 27;10:223-236. doi: 10.1016/j.omtm.2018.07.004. eCollection 2018 Sep 21.

Electrochemically Promoted Tyrosine-Click-Chemistry for Protein Labelling
Alvarez-Dorta D, Thobie-Gautier C, Croyal M, Bouzelha M, Mével M, Deniaud D, Boujtita M, Gouin SG
J Am Chem Soc. 2018 Nov 28. doi: 10.1021/jacs.8b09372

2017

An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21-/- mouse model
Perdomini M, Dos Santos C, Goumeaux C, Blouin V, Bougnères P.
Gene Ther. 2017 Feb 10.

Accurate identification and quantification of DNA species by next-generation sequencing in adeno-associated viral vectors produced in insect cells.
Penaud-Budloo M, Lecomte E, Guy-Duché A, Saleun S, Roulet A, Lopez-Roques C2, Tournaire B, Cogné B, Léger A, Blouin V, Lindenbaum P, Moullier P, Ayuso E. Hum Gene Ther Methods. 2017 May 2. doi: 10.1089/hgtb.2016.185.

Outer Plexiform Layer Structures Are Not Altered Following AAV-Mediated Gene Transferin Healthy Rat Retina.
Giers C, Klein D, Mendes-Madeira A, Isiegas C, Lorenz B, Haverkamp S, Stieger K.
Frontiers in Neurology. 2017-Feb-23..

Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
Grosse S, Penaud-Budloo M, Herrmann AK1, Börner K1, Fakhiri J, Laketa V, Krämer C, Wiedtke E, Gunkel M, Ménard L, Ayuso E, Grimm D.
J Virol. 2017 Sep 27;91(20). pii: e01198-17. doi: 10.1128/JVI.01198-17. Print 2017 Oct 15.

AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations.
Pacouret S, Bouzelha M, Shelke R, Andres-Mateos E, Xiao R, Maurer A, Mevel M, Turunen H, Barungi T, Penaud-Budloo M, Broucque F, Blouin V, Moullier P, Ayuso E, Vandenberghe LH.
Mol Ther. 2017 Jun 7;25(6):1375-1386. doi: 10.1016/j.ymthe.2017.04.001. Epub 2017 Apr 17.

Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial.
Vandamme C, Adjali O, Mingozzi F.
Hum Gene Ther. 2017 Nov;28(11):1061-1074. doi: 10.1089/hum.2017.150.

Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.
Fraysse B, Barthélémy I, Qannari EM, Rouger K, Thorin C, Blot S, Le Guiner C, Chérel Y, Hogrel JY.
BMC Musculoskelet Disord. 2017 Apr 12;18(1):153. doi: 10.1186/s12891-017-1494-4.

Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
Bey K, Ciron C, Dubreil L, Deniaud J, Ledevin M, Cristini J, Blouin V, Aubourg P, Colle MA.
Gene Ther. 2017 May 24.

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Le Guiner C, Servais L, Montus M, Larcher T, Fraysse B, Moullec S, Allais M, François V, Dutilleul M, Malerba A, Koo T, Thibaut JL, Matot B, Devaux M, Le Duff J, Deschamps JY, Barthelemy I, Blot S, Testault I, Wahbi K, Ederhy S, Martin S, Veron P, Georger C, Athanasopoulos T, Masurier C, Mingozzi F, Carlier P, Gjata B, Hogrel JY, Adjali O, Mavilio F, Voit T, Moullier P, Dickson G.
Nat Commun. 2017 Jul 25;8:16105. doi: 10.1038/ncomms16105.

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.
Hordeaux J, Dubreil L, Robveille C, Deniaud J, Pascal Q, Dequéant B, Pailloux J, Lagalice L, Ledevin M, Babarit C, Costiou P, Jamme F, Fusellier M, Mallem Y, Ciron C, Huchet C, Caillaud C, Colle MA.
Acta Neuropathol Commun. 2017 Sep 6;5(1):66. doi: 10.1186/s40478-017-0464-2.

Skeletal muscle relaxant effect of a standardized extract of Valeriana officinalis L. after acute administration in mice.
Caudal D, Guinobert I, Lafoux A, Bardot V, Cotte C, Ripoche I, Chalard P, Huchet C.
J Tradit Complement Med. 2017 Oct 12;8(2):335-340

2016

Manufacturing of recombinant AAV vectors: new technologies are welcome
Ayuso E.
Mol Ther Methods & Clinical Development (2016) 3, 15049; doi:10.1038/mtm.2015.49

AAV-mediated gene therapy halts retinal degeneration in PDE6β-deficient dogs.
Pichard V, Provost N, Mendes-Madeira A, Libeau L, Hulin P, Tshilenge KT, Biget M, Ameline B, Deschamps JY, Weber M, Le Meur G, Colle MA, Moullier P, Rolling F.
Mol Ther. 2016 Feb 9. doi: 10.1038/mt.2016.37. [Epub ahead of print] PMID: 26857842

Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR.
PD’Costa S, Blouin V, Broucque F, Penaud-Budloo M, A François, IC. Perez, Le Bec C, Moullier P, Snyder RO and Ayuso E.
Mol Ther Methods Clin Dev. 2016 Mar

Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates.
Tshilenge KT, Ameline B, Weber M, Mendes-Madeira A, Nedellec S, Biget M, Provost N, Libeau L, Blouin V, Deschamps JY, Le Meur G, Colle MA, Moullier P, Pichard V, Rolling
F. Hum Gene Ther Methods. 2016 Jun

Seipin deficiency alters brown adipose tissue thermogenesis and insulin sensitivity in a non-cell autonomous mode.
Dollet L, Magré J, Joubert M, Le May C, Ayer A, Arnaud L, Pecqueur C, Blouin V, Cariou B, Prieur X.
Sci Rep. 2016 Oct

A fragmented adeno-associated viral dual vector strategy for treatment of diseases caused by mutations in large genes leads to expression of hybrid transcripts.
McClements ME, Charbel Issa P, Blouin V, MacLaren RE.
J Genet Syndr Gene Ther. 2016 Nov 14

Soluble Milk Protein Supplementation with Moderate Physical Activity Improves Locomotion Function in Aging Rats.
Lafoux A, Baudry C, Bonhomme C, Le Ruyet P, Huchet C.
PLoS One. 2016 Dec 14;11(12):e0167707. doi: 10.1371/journal.pone.0167707. eCollection 2016.

2015

Efficient central nervous system aavrh10-mediated intrathecal gene transfer in adult and neonate rats.
Hordeaux J, Dubreil L, Deniaud J, Iacobelli F, Moreau S, Ledevin M, Le Guiner C, Blouin V, Mendes-Madeira A, Rolling F, Cherel Y, Moullier P, Colle M.
Gene Ther. 2015

Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxydative damage to transgene mRNA.
Dupont JB, Tournaire B, Georger C, Marolleau B, Jeanson-Leh L, Ledevin M, Lindenbaum P, Lecomte E, Cogné B, Dubreil L, Larcher T, Gjata B, Van Wittenberghe L, Le Guiner C, Penaud-Budloo M, O Snyder R, Moullier P, Léger A.
Molecular Therapy – Methods and clinical Development (2015) 2, 15010

Advanced characterization of DNA molécules in rAAV vector préparations by single-stranded virus next-generation sequencing. Mol Ther Nucleic Acids.
Lecomte E, Tournaire B, Cogné B, Dupont JB, Lindenbaum P, Martin-Fontaine M, Broucque F, Robin C, Hebben M, Merten OW, Blouin V, François A, Redon R, Moullier P, Léger A.
2015 Oct 27;4:e260. doi: 10.1038/mtna.2015.32.

Use of adeno-associated virus to enrich cardiomyocytes derived from human stem cells.
Guan X, Wang Z, Czerniecki S, Mack D, François V, Blouin V, Moullier P, Childers MK.
Hum Gene Ther Clin Dev. 2015 Sep;26(3):194-201. doi: 10.1089/humc.2015.052. Epub 2015 Aug 7.

Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
Gernoux G, Guilbaud M, Dubreil L, Larcher T, Babarit C, Ledevin M, Jaulin N, Planel P, Moullier P, Adjali O.
Hum Gene Ther, 2015, 26 : 1-13, DOI 10.1089/hum.2014.070

Identification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells.
Teichenne J, Morró M, Casellas A, Jimenez V, Tellez N, Leger A, Bosch F, Ayuso E.
PLoS One. 2015 Dec 21;10(12):e0145116. doi: 10.1371/journal.pone.0145116.

    Before 2015

Updated on 23 May 2025.